1 / 14

Effect of Calorie Restriction on Doxorubicin Induced Cardiac Dysfunction

Effect of Calorie Restriction on Doxorubicin Induced Cardiac Dysfunction. Celina Lucero Genysie Van Duren. Background: Doxorubicin (DOX). Potent Chemotherapy Effective against: Solid tumors Leukemia breast cancer Destroys cells by: Apoptosis DNA damage. L eukemia. DNA damage.

marek
Download Presentation

Effect of Calorie Restriction on Doxorubicin Induced Cardiac Dysfunction

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Effect of Calorie Restriction on Doxorubicin Induced Cardiac Dysfunction Celina Lucero Genysie Van Duren

  2. Background: Doxorubicin (DOX) • Potent Chemotherapy • Effective against: • Solid tumors • Leukemia • breast cancer • Destroys cells by: • Apoptosis • DNA damage Leukemia DNA damage

  3. Background: DOX • Problem: • Attacks all metabolically active cells • Damages cardiac tissue • Creates reactive oxygen species and oxidative stress • Side Effects: • Cardiomyopathy • Severe acute illnesses • “Red Death” Cardiac tissue

  4. Background: Calorie Restriction (CR) • Form of dieting • Proven to: • Extend lifespan • Preserves cardiac function • Lower body weight • Differing Effects: • Acute= negative results • Chronic= positive results

  5. Introduction • Used rats: • Split into 4 groups- • Ad Lib (AL)+Saline (SAL), AL+DOX, CR+SAL, and CR+DOX • Done over 4 weeks • Echocardiographs monitor heart: • M-mode= left ventricle • Doppler= mitral and aortic valves Ekg: echocardiogram

  6. Hypothesis/Purpose • Known facts: • DOX= effective…but dangerous • CR= prolong heart functions • Combination? • Both together= beneficial? • Solve adverse effects of DOX • Safer use with patients

  7. Methods • Used Sprague-Dawley(Rattusnorvegicus) rats. • Reliable and healthy subjects • Feeding: • Normal first 2 weeks • CR or AL treatments follow initial 2 weeks. • CR= 60% of AL intake

  8. Methods • Timeline Instructions • At 10 wks animals (males and females) assigned to feeding and activity regimens. • After a 2 week acclamation the DOX treatment will start • On weeks 2-9 the animals will receive either saline or DOX at 2.5 mg/kg for a total dose of 20 mg/kg

  9. Results • Body Mass: • General decrease. CR= more • No significant differences • M-mode: • Variables generally the same • Corrected velocity of circumferential shortening (Vcfa) was only significant difference. • Between CR+DOX and AL+DOX • Doppler: • Variables generally the same • No significant differences

  10. Results Table 1.Body Weight Averages Average body weights (g) over the course of the experiment. Number in parenthesis represent the standard deviation (StDev).

  11. Results Percentage * mm/sec Fractional shortening at week 4. Percentage of wall change during diastole to systole. Vcfa at week 4. Speed at which the percentage change from FS happens adjusted to heart size. *The black portion of the graph represents the standard error. Diastole= relaxation Systole= contraction

  12. Discussion • Body Mass: • CR= more weight loss • DOX did not effect weight • DOX normally lowers weight • M-mode: • Little thinning in LV walls • Previous study= profound thinning in LV walls • Doppler: • No significant differences • Fatalities: • Two rats in DOX group Top: M-mode Bottom: Doppler

  13. Recommendations • Time Constraints: • Chronic CR proven to be better • Rats did not have enough time. • Only 7.5 mg/kg of DOX injected cumulatively • Previous studies= larger amount DOX • Again longer period of time • Rats not exposed to DOX long enough • Subjects: • Small sample size, decreased power

  14. Acknowledgments • Thank you for everything! • Mentors: • Stephanie Greufe • Reid Hayward • Advisor: • Nick Horianopoulos • FSI Director: • Lori Ball • Sponsors: • Kinder Morgan Foundation • Xcel Energy Foundation • Frank and Gloria Walsh Science Foundation • Suncor Energy

More Related